rs6162
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in clinvar |
| Make rs6162(A;A) |
| Make rs6162(A;G) |
| Reference | GRCh38 38.1/142 |
| Chromosome | 10 |
| Position | 102837224 |
| Gene | CYP17A1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs6162 |
| dbSNP (classic) | rs6162 |
| ClinGen | rs6162 |
| ebi | rs6162 |
| HLI | rs6162 |
| Exac | rs6162 |
| Gnomad | rs6162 |
| Varsome | rs6162 |
| LitVar | rs6162 |
| Map | rs6162 |
| PheGenI | rs6162 |
| Biobank | rs6162 |
| 1000 genomes | rs6162 |
| hgdp | rs6162 |
| ensembl | rs6162 |
| geneview | rs6162 |
| scholar | rs6162 |
| rs6162 | |
| pharmgkb | rs6162 |
| gwascentral | rs6162 |
| openSNP | rs6162 |
| 23andMe | rs6162 |
| SNPshot | rs6162 |
| SNPdbe | rs6162 |
| MSV3d | rs6162 |
| GWAS Ctlg | rs6162 |
| GMAF | 0.4288 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
[PMID 23186779] Molecular markers in Key Steroidogenic Pathways, Circulating steroid levels and Prostate Cancer progression
[PMID 18163429
] Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.
[PMID 20411041] Common Variation in the CYP17A1 and IFIT1 Genes on Chromosome 10 Does Not Contribute to the Risk of Endometriosis.
[PMID 21656827] CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.
[PMID 22714708] Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy.
| ClinVar | |
|---|---|
| Risk | rs6162(A;A) |
| Alt | rs6162(A;A) |
| Reference | Rs6162(G;G) |
| Significance | Non-pathogenic |
| Disease | Congenital adrenal hyperplasia |
| Variation | info |
| Gene | CYP17A1 |
| CLNDBN | Congenital adrenal hyperplasia |
| Reversed | 0 |
| HGVS | NC_000010.10:g.104596981G>A |
| CLNSRC | |
| CLNACC | RCV000403468.1, |
